| ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools’ Microfluidics Business, Now Biomark Scientific |
Globe Newswire |
11/03 |
07:30 |
| Creative Realities, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call Information |
Globe Newswire |
11/03 |
07:30 |
| Palvella Therapeutics to Participate in the Stifel 2026 Healthcare Conference |
Globe Newswire |
11/03 |
07:30 |
| HNI Corporation Reports Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:30 |
| Ascentage Pharma to Participate in Two Upcoming Investor Conferences in London |
Globe Newswire |
11/03 |
07:30 |
| AI’s Biggest Chips Are Starving. |
Globe Newswire |
11/03 |
07:25 |
| IBN Introduces North America Media Network: Expanding News Distribution Across the U.S. and Canada |
Globe Newswire |
11/03 |
07:17 |
| Decoy Therapeutics Provides Third Quarter 2026 Business Update |
Globe Newswire |
11/03 |
07:15 |
| Hydrofarm Eliminates $109 Million in Debt, Becoming Debt-Free |
Globe Newswire |
11/03 |
07:15 |
| Nexera Technologies: Subsidiary Fort Technology Announces Receipt of Approval for a Voluntary Delisting of its Common Shares From the TSX Venture Exchange |
Globe Newswire |
11/03 |
07:15 |
| Xometry Reports Record Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:05 |
| UPDATE: Accelerated Wealth Partners Enters into Definitive Agreement to Partner with $5 Billion Wealth Manager Pallas Capital Advisors |
Globe Newswire |
11/03 |
07:00 |
| Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| OutSolve Named a 2026 Inc. Power Partner for Business Products and Services |
Globe Newswire |
11/03 |
07:00 |
| ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026 |
Globe Newswire |
11/03 |
07:00 |
| LGI Homes, Inc. Reports Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| Fiserv Reports Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| OTC Markets Group Announces Quarterly Index Performance and Rebalancing |
Globe Newswire |
11/03 |
07:00 |
| Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion |
Globe Newswire |
11/03 |
07:00 |
| Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22% |
Globe Newswire |
11/03 |
07:00 |
| InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day |
Globe Newswire |
11/03 |
07:00 |
| Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients |
Globe Newswire |
11/03 |
07:00 |
| Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors |
Globe Newswire |
11/03 |
07:00 |
| Strata Critical Medical Announces Third Quarter 2026 Results |
Globe Newswire |
11/03 |
07:00 |
| Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026 |
Globe Newswire |
11/03 |
07:00 |
